Bradley A White, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1903 E Beebe Capps Blvd, Searcy, AR 72143 Phone: 501-279-3838 Fax: 501-279-1212 |
News Archive
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has entered into a license agreement with Clinuvel Pharmaceuticals Limited of Melbourne, Australia. Under the agreement, the Company's SurModics Pharmaceuticals unit has licensed certain of its biodegradable polymer implant technology to Clinuvel for the treatment of sun-induced skin disorders. Terms of the agreement were not disclosed.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
A counterintuitive experiment has resulted in one of the longest recorded life-span extensions in any organism and opened a new door for anti-aging research in humans.
The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.
› Verified 8 days ago